Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IBBQ vs. FBDIX: which is better?

Bottom line

IBBQ vs FBDIX: the short answer

IBBQ (Invesco Nasdaq Biotechnology ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are quite different portfolios: only about 38% of their top holdings (by weight) are shared.

But IBBQ is far broader, holding 261 positions to 126 for FBDIX, so beyond the top names it adds exposure FBDIX doesn't have.

IBBQ is cheaper at 0.19% vs 1.01% — a difference of $82 a year per $10,000 invested.

Over one year, FBDIX returned +43.9% vs −0.6% for IBBQ (reporting dates differ).

FBDIX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

IBBQ vs FBDIX side by side

IBBQFBDIX
TypeETFMutual fund
Fund familyInvescoFranklin Templeton
CategoryTechnology SectorTechnology Sector
Expense ratio0.19%1.01%
Annual cost per $10k$19$101
10-yr cost on $10k (prospectus)$242$1,728
Max front loadNone5.5%
12b-1 fee—0.25%
1-yr return−0.6%+43.9%
5-yr return (annualized)—+5.0%
10-yr return (annualized)—+6.4%
Best quarter+12.0%+29.5%
Worst quarter−11.7%−24.5%
Net assets (fund)$67.4M$1.2B
Number of holdings261126
Portfolio turnover17%38%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIBBQFBDIXDifference
2024−0.6%+4.0%−4.6%
2023+4.5%+18.4%−13.9%
2022−10.2%−12.7%+2.4%

Source: Fund prospectus bar charts

Holdings overlap

10 of IBBQ's top 25 holdings also appear in FBDIX's top 25.

Shared top holdings
HoldingIBBQFBDIX
Gilead Sciences, Inc.7.39%3.86%
Vertex Pharmaceuticals Inc.7.38%3.54%
Amgen Inc.7.10%4.39%
Regeneron Pharmaceuticals, Inc.5.08%3.77%
Revolution Medicines, Inc.2.48%3.01%
argenx SE1.89%3.62%
Insmed Inc.1.83%1.99%
Guardant Health, Inc.1.35%2.76%
Neurocrine Biosciences, Inc.1.26%1.82%
BridgeBio Pharma, Inc.1.02%1.67%

Source: SEC Form N-PORT

IBBQ top 10

  1. Invesco Private Prime Fund — 14.20%
  2. Gilead Sciences, Inc. — 7.39%
  3. Vertex Pharmaceuticals Inc. — 7.38%
  4. Amgen Inc. — 7.10%
  5. Invesco Private Government Fund — 5.48%
  6. Regeneron Pharmaceuticals, Inc. — 5.08%
  7. Alnylam Pharmaceuticals, Inc. — 3.19%
  8. Revolution Medicines, Inc. — 2.48%
  9. Biogen Inc. — 2.29%
  10. Illumina, Inc. — 1.98%

FBDIX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

FAQ

What is the difference between IBBQ and FBDIX?
IBBQ (Invesco Nasdaq Biotechnology ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are quite different portfolios: only about 38% of their top holdings (by weight) are shared. But IBBQ is far broader, holding 261 positions to 126 for FBDIX, so beyond the top names it adds exposure FBDIX doesn't have.
Which is cheaper, IBBQ or FBDIX?
IBBQ has the lower expense ratio (0.19%).
Should I own both IBBQ and FBDIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.